A AARDVARK THERAPEUTICS Trademark

Trademark Overview


On Sunday, November 17, 2024, a trademark application was filed for A AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the A AARDVARK THERAPEUTICS trademark a serial number of 98977962. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Saturday, April 18, 2026. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The A AARDVARK THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro psychological disorders, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro psychological disorders, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro psychological disorders, ...
a aardvark therapeutics

General Information


Serial Number98977962
Word MarkA AARDVARK THERAPEUTICS
Filing DateSunday, November 17, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSaturday, April 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 29, 2025

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro psychological disorders, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro psychological disorders, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro psychological disorders, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
Description of MarkThe mark consists of the wording A AARDVARK THERAPEUTICS. The wording AARDVARK THERAPEUTICS appears in lower-case spelling on two lines with a stylized letter capital A to the left of the wording. The horizontal line in the letter A is replaced with a series of nine shaded circles in a curved line.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 17, 2024
Primary Code042
First Use Anywhere DateFriday, November 29, 2019
First Use In Commerce DateFriday, November 29, 2019

Trademark Owner History


Party NameAARDVARK THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
US

Party NameAARDVARK THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
US

Trademark Events


Event DateEvent Description
Sunday, November 17, 2024NEW APPLICATION ENTERED
Friday, May 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 14, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 23, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 23, 2026SOU TEAS EXTENSION RECEIVED
Monday, March 23, 2026TEAS REQUEST TO DIVIDE RECEIVED
Monday, March 23, 2026TEAS STATEMENT OF USE RECEIVED
Wednesday, April 1, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 1, 2026ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, April 1, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 23, 2026DIVISIONAL REQUEST RECEIVED
Friday, April 3, 2026DIVISIONAL PROCESSING COMPLETE
Tuesday, March 31, 2026SOU EXTENSION 1 FILED
Friday, April 3, 2026SOU EXTENSION 1 GRANTED
Wednesday, April 1, 2026RESPONSE TO ITU OFFICE ACTION ENTERED
Monday, March 23, 2026USE AMENDMENT FILED
Friday, April 3, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, April 3, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2026TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 18, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 18, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 18, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED